VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Curileum

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Advancing a novel pan-PPAR agonist to restore the health of gastrointestinal tissues and prevent bowel cancer.

  • Biotech & therapeutics
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Curileum is discovering drugs to intervene in serious intestinal disease. They currently have three pipeline drugs treating bowel cancer, anal fistulas, and chronic inflammation respectively.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy